These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8369643)

  • 1. Human brain fluoxetine concentrations.
    Karson CN; Newton JE; Livingston R; Jolly JB; Cooper TB; Sprigg J; Komoroski RA
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):322-9. PubMed ID: 8369643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.
    Renshaw PF; Guimaraes AR; Fava M; Rosenbaum JF; Pearlman JD; Flood JG; Puopolo PR; Clancy K; Gonzalez RG
    Am J Psychiatry; 1992 Nov; 149(11):1592-4. PubMed ID: 1415832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine.
    Norman TR; Gupta RK; Burrows GD; Parker G; Judd FK
    Int Clin Psychopharmacol; 1993; 8(1):25-9. PubMed ID: 8473717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
    Amsterdam JD; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Michelson D; Hornig-Rohan M; Beasley CM
    Am J Psychiatry; 1997 Jul; 154(7):963-9. PubMed ID: 9210747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy.
    Bolo NR; Hodé Y; Nédélec JF; Lainé E; Wagner G; Macher JP
    Neuropsychopharmacology; 2000 Oct; 23(4):428-38. PubMed ID: 10989270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fluoxetine and norfluoxetine concentrations and antidepressant response.
    Kelly MW; Perry PJ; Holstad SG; Garvey MJ
    Ther Drug Monit; 1989; 11(2):165-70. PubMed ID: 2785723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain.
    Komoroski RA; Newton JE; Cardwell D; Sprigg J; Pearce J; Karson CN
    Magn Reson Med; 1994 Feb; 31(2):204-11. PubMed ID: 8133756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of fluoxetine in the clinical treatment setting.
    Lundmark J; Reis M; Bengtsson F
    Ther Drug Monit; 2001 Apr; 23(2):139-47. PubMed ID: 11294514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography.
    Wong SH; Dellafera SS; Fernandes R; Kranzler H
    J Chromatogr; 1990 Jan; 499():601-8. PubMed ID: 2324217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine/norfluoxetine concentrations in human milk.
    Burch KJ; Wells BG
    Pediatrics; 1992 Apr; 89(4 Pt 1):676-7. PubMed ID: 1557252
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study.
    Karson CN; Newton JE; Mohanakrishnan P; Sprigg J; Komoroski RA
    Psychiatry Res; 1992 Aug; 45(2):95-104. PubMed ID: 1362616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?
    Castrogiovanni P; Blardi P; De Lalla A; Dell'Erba A; Auteri A
    Psychopharmacol Bull; 2003; 37(2):102-8. PubMed ID: 14566218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.
    Strauss WL; Layton ME; Hayes CE; Dager SR
    Am J Psychiatry; 1997 Apr; 154(4):516-22. PubMed ID: 9090339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetization transfer of fluoxetine in the human brain using fluorine magnetic resonance spectroscopy.
    Strauss WL; Dager SR
    Biol Psychiatry; 2001 May; 49(9):798-802. PubMed ID: 11331088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia.
    Miner CM; Davidson JR; Potts NL; Tupler LA; Charles HC; Krishnan KR
    Biol Psychiatry; 1995 Nov; 38(10):696-8. PubMed ID: 8555383
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study.
    Henry ME; Schmidt ME; Hennen J; Villafuerte RA; Butman ML; Tran P; Kerner LT; Cohen B; Renshaw PF
    Neuropsychopharmacology; 2005 Aug; 30(8):1576-83. PubMed ID: 15886723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.
    Beasley CM; Bosomworth JC; Wernicke JF
    Psychopharmacol Bull; 1990; 26(1):18-24. PubMed ID: 2196623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell and plasma concentrations of fluoxetine and norfluoxetine.
    Amitai Y; Kennedy E; DeSandre P; Fawcett J; Frischer H
    Vet Hum Toxicol; 1993 Apr; 35(2):134-6. PubMed ID: 8470355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.
    Neudeck BL; Taddonio TE; Garner WL; Welage LS
    Pharmacotherapy; 1998; 18(4):851-5. PubMed ID: 9692660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.